aspirin has been researched along with g 4120 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collen, D; Gold, HK; Imura, Y; Lesaffre, E; Stassen, JM; Vreys, I | 1 |
| Hoylaerts, MF; Nyström, A; Stassen, JM; Stockmans, F; Vermylen, J | 1 |
| Rossi, G | 1 |
3 other study(ies) available for aspirin and g 4120
| Article | Year |
|---|---|
Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
Topics: Animals; Antithrombins; Arginine; Aspirin; Blood Coagulation; Cricetinae; Disease Models, Animal; Drug Synergism; Femoral Vein; Fibrinolytic Agents; Hemostasis; Heparin; Injections, Intravenous; Male; Peptides, Cyclic; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Sulfoxides; Thrombosis | 1992 |
A technique to investigate microvascular mural thrombus formation in arteries and veins: II. Effects of aspirin, heparin, r-hirudin, and G-4120.
Topics: Animals; Anticoagulants; Aspirin; Carotid Artery Thrombosis; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Femoral Vein; Heparin; Hirudin Therapy; Linear Models; Male; Partial Thromboplastin Time; Peptides, Cyclic; Platelet Aggregation Inhibitors; Sulfoxides; Thrombosis | 1997 |
[Superaspirin in the platelet aggregation inhibitor therapy].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine | 1997 |